Wesseling J - Search Results

1

Detection of micrometastatic breast cancer by means of real time quantitative RT-PCR and immunostaining in perioperative blood samples and sentinel nodes.

Schröder CP, Ruiters MHJ, de Jong S, Tiebosch ATMG, Wesseling J, Veenstra R, de Vries J, Hoekstra HJ, de Leij LFMH, de Vries EGE. Schröder CP, et al. Among authors: wesseling j. Int J Cancer. 2003 Sep 10;106(4):611-618. doi: 10.1002/ijc.11295. Int J Cancer. 2003. PMID: 12845661

2

Tissue distribution of the death ligand TRAIL and its receptors.

Spierings DC, de Vries EG, Vellenga E, van den Heuvel FA, Koornstra JJ, Wesseling J, Hollema H, de Jong S. Spierings DC, et al. Among authors: wesseling j. J Histochem Cytochem. 2004 Jun;52(6):821-31. doi: 10.1369/jhc.3A6112.2004. J Histochem Cytochem. 2004. PMID: 15150291

3

Doxorubicin potentiates TRAIL cytotoxicity and apoptosis and can overcome TRAIL-resistance in rhabdomyosarcoma cells.

Komdeur R, Meijer C, Van Zweeden M, De Jong S, Wesseling J, Hoekstra HJ, van der Graaf WT. Komdeur R, et al. Among authors: wesseling j. Int J Oncol. 2004 Sep;25(3):677-84. doi: 10.3892/ijo.25.3.677. Int J Oncol. 2004. PMID: 15289869

4

Axillary recurrence after sentinel lymph node biopsy.

van der Vegt B, Doting MH, Jager PL, Wesseling J, de Vries J. van der Vegt B, et al. Among authors: wesseling j. Eur J Surg Oncol. 2004 Sep;30(7):715-20. doi: 10.1016/j.ejso.2004.05.015. Eur J Surg Oncol. 2004. PMID: 15296984

5

TRAIL induces apoptosis in human colorectal adenoma cell lines and human colorectal adenomas.

Jalving M, de Jong S, Koornstra JJ, Boersma-van Ek W, Zwart N, Wesseling J, de Vries EG, Kleibeuker JH. Jalving M, et al. Among authors: wesseling j. Clin Cancer Res. 2006 Jul 15;12(14 Pt 1):4350-6. doi: 10.1158/1078-0432.CCR-05-2487. Clin Cancer Res. 2006. PMID: 16857810

6

Increased risk of fundic gland polyps during long-term proton pump inhibitor therapy.

Jalving M, Koornstra JJ, Wesseling J, Boezen HM, DE Jong S, Kleibeuker JH. Jalving M, et al. Among authors: wesseling j. Aliment Pharmacol Ther. 2006 Nov 1;24(9):1341-8. doi: 10.1111/j.1365-2036.2006.03127.x. Aliment Pharmacol Ther. 2006. PMID: 17059515

7

p53 overexpression is a predictor of local recurrence after treatment for both in situ and invasive ductal carcinoma of the breast.

de Roos MA, de Bock GH, de Vries J, van der Vegt B, Wesseling J. de Roos MA, et al. Among authors: wesseling j. J Surg Res. 2007 Jun 1;140(1):109-14. doi: 10.1016/j.jss.2006.10.045. Epub 2007 Feb 7. J Surg Res. 2007. PMID: 17291532 Free article.

8

Pathological and biological differences between screen-detected and interval ductal carcinoma in situ of the breast.

de Roos MA, van der Vegt B, de Vries J, Wesseling J, de Bock GH. de Roos MA, et al. Among authors: wesseling j. Ann Surg Oncol. 2007 Jul;14(7):2097-104. doi: 10.1245/s10434-007-9395-7. Epub 2007 Apr 24. Ann Surg Oncol. 2007. PMID: 17453296 Free PMC article.

9

The expression pattern of MUC1 (EMA) is related to tumour characteristics and clinical outcome in 'pure' ductal carcinoma in situ of the breast.

de Roos MA, van der Vegt B, Peterse JL, Patriarca C, de Vries J, de Bock GH, Wesseling J. de Roos MA, et al. Among authors: wesseling j. Histopathology. 2007 Aug;51(2):227-38. doi: 10.1111/j.1365-2559.2007.02754.x. Histopathology. 2007. PMID: 17650217

10

Independent induction of caspase-8 and cFLIP expression during colorectal carcinogenesis in sporadic and HNPCC adenomas and carcinomas.

Heijink DM, Kleibeuker JH, Jalving M, Boersma-van Ek W, Koornstra JJ, Wesseling J, de Jong S. Heijink DM, et al. Among authors: wesseling j. Cell Oncol. 2007;29(5):409-19. doi: 10.1155/2007/564605. Cell Oncol. 2007. PMID: 17726263 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

386 results

Search Page

Filters